Skip to content

Clinical trials

Completed Atherosclerosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20102
20112
20121
20132
20143
20154
20162
20172
20183
20211
20222
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Xuanwu Hospital, Beijing3
Boston Scientific Corporation2
Novartis Pharmaceuticals2
Sun Yat-sen University2
Amgen1
AstraZeneca1
Beijing Inno Medicine Co., Ltd.1
C. R. Bard1
China National Center for Cardiovascular Diseases1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis32
Cardiovascular Diseases4
Coronary Disease4
Stroke4
Ischemia3
Coronary Artery Disease2
Dyslipidemias2
Heart Diseases2
Hypercholesterolemia2
Acute Coronary Syndrome1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.